Eledon Pharmaceuticals Inc (FRA:2TK)
€ 2.4 0.02 (0.84%) Market Cap: 98.19 Mil Enterprise Value: 58.42 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 36/100

Eledon Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 15, 2023 / 10:00PM GMT
Release Date Price: €2.52 (-3.08%)
Tom Smith
SVB Securities LLC - Analyst

All right. Good afternoon, everyone. Thanks for joining us here at the SVB Securities Global Biopharma Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at SVB Securities. And excited to welcome our next presenting company, Eledon Pharmaceuticals. And from the company, very happy to be joined by CEO, DA Gros; and President and CSO, Steve Perrin. Gentlemen, thanks for joining us.

DA Gros
Eledon Pharmaceuticals, Inc. - CEO

Tom, thank you so much. It's a pleasure to be part of the conference again.

Tom Smith
SVB Securities LLC - Analyst

Excellent. (Conference Instructions). And with that, DA, why don't I hand it over to you to run through any -- you have some slides, and then we can come back to a Q&A towards the end.

DA Gros
Eledon Pharmaceuticals, Inc. - CEO

That sounds great. Thank you. We will be making some forward-looking statements today, so I urge everyone to please look at this slide as well

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot